UBS Maintains Buy on Omega Healthcare Invts, Raises Price Target to $56

Benzinga · 1d ago
UBS analyst Michael Goldsmith maintains Omega Healthcare Invts (NYSE:OHI) with a Buy and raises the price target from $52 to $56.